Anixa Biosciences, Inc. - ANIX
About Gravity Analytica
Recent News
- 06.11.2026 - Anixa Biosciences Announces Presentations of Two Clinical-Stage Immunotherapy Programs at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium
- 06.10.2026 - 10-Q - Quarterly report [Sections 13 or 15(d)]
- 06.01.2026 - Anixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance
- 05.11.2026 - Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy
- 05.01.2026 - Anixa Biosciences Interview to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV
- 04.29.2026 - Anixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology
- 04.22.2026 - Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting
- 04.14.2026 - SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership
- 04.09.2026 - Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026
- 04.07.2026 - Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026